MGEN - Miragen Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Insider Roster

Individual or Entity	Most Recent Transaction	Date	Shares Owned as of Transaction Date
GONYER DAVID A Director	Conversion of Exercise of derivative security	Feb 7, 2017	1,899
HUGHES THOMAS E Director	Sale	Dec 19, 2017	2,827
LEBOW BENNETT S Director and Beneficial Owner of more than 10% of a Class of Security	Conversion of Exercise of derivative security	Feb 12, 2017	429,441
LEVERONE JASON A. CPA Chief Financial Officer	Conversion of Exercise of derivative security	Aug 22, 2019	36,330
MARSHALL WILLIAM STUART PH.D. Chief Executive Officer	Conversion of Exercise of derivative security	Feb 12, 2018	265,646
RICCITELLI SAMUEL D Chief Executive Officer	Conversion of Exercise of derivative security	Oct 30, 2016	571,370
SCHULING DOUGLAS A Director	Stock Award(Grant)	Aug 5, 2015	10,500
SMITH ROBIN L Director	Stock Award(Grant)	Aug 5, 2015	10,500
*Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.